Karin Hohloch

Retrospective web-based multicenter evaluation of 18F-FDG-PET and CT derived predictive factors

U. Nestle, D. Hellwig, C. Kirsch, 2010, Nuklearmedizin.

Radioimmunotherapy with 90Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network

P. Zinzani, P. Zinzani, G. Wulf, 2011, Bone Marrow Transplantation.